HOME > News Releases

News Releases

2016.09.20
R&D
PDF/188KB
Sunovion Announces Results from Pivotal Study Evaluating Novel Drug Candidate Dasotraline in Children with ADHD
2016.09.01
Corporate
PDF/102KB
Sumitomo Dainippon Pharma’s U.S. Subsidiary Sunovion to Acquire Cynapsus Therapeutics Inc. (Canadian Specialty Central Nervous System Biotechnology Company)
2016.08.30
Corporate
PDF/132KB
Sumitomo Dainippon Pharma announces offering an Early Retirement Program to Japanese Employees and Reduction in Executive Remuneration
2016.07.29
R&D
PDF/316KB
Sunovion Submits New Drug Application for SUN-101/eFlow to the FDA for the Treatment of Patients with Chronic Obstructive Pulmonary Disease (COPD)
2016.07.27
Finances
PDF/537KB
Supplementary Financial Data for the First Quarter of the Year Ending March 31, 2017
2016.07.27
Finances
PDF/283KB
Summary of Consolidated Financial Results for the First Quarter of the Year Ending March 31, 2017[Japanese GAAP](Unaudited)

Page Top